Surrozen Inc (SRZN)
Healthcare
Biotechnology
21.80 $
-1.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Surrozen Inc (SRZN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.7 | -10 | -7.3 | -8.7 | -5.6 | -6.8 | 3.5 | -9.3 | -6.1 | -9.0 | -5.8 | -12 | -33 | |
| 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 | 0.0 | 0.1 | 0.3 | |
| 1.2 | 0.9 | 1.2 | 1.0 | 1.1 | 1.0 | 0.9 | 0.8 | 1.0 | 1.0 | 1.0 | 2.1 | 5.1 | |
| 1.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.8 | -1.1 | -0.2 | -1.8 | 0.9 | 0.8 | 10 | -1.4 | 0.5 | -0.4 | 4.4 | -5.6 | -1.0 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | |
| 17 | 7.6 | – | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | -0.2 | |
| – | 0.0 | – | 0.0 | – | 0.0 | 0.1 | – | 0.1 | – | 0.1 | – | – | |
| 0.2 | 0.0 | 0.1 | 0.1 | 16 | 0.0 | 0.1 | 76 | -5.1 | 0.0 | 14 | 30 | 39 | |
| 8.7 | -2.5 | 2.3 | -8.8 | 10 | -6.8 | 3.6 | 67 | -11 | -9.1 | 7.9 | 18 | 5.3 | |
| -8.8 | -10 | -7.3 | -8.8 | -5.6 | -6.8 | 3.5 | -9.3 | -6.1 | -9.1 | -5.9 | -13 | -34 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.